219 related articles for article (PubMed ID: 30184038)
41. A 33-year follow-up after valvular surgery for carcinoid heart disease.
Bergsten J; Flachskampf FA; Lundin L; Öhagen P; Albåge A
Eur Heart J Cardiovasc Imaging; 2022 Mar; 23(4):524-531. PubMed ID: 33899077
[TBL] [Abstract][Full Text] [Related]
42. Inoperable Primary Ovarian Carcinoid Led to the Progression of Carcinoid Heart Disease From Right-Sided to Both-Sided Involvement.
Tadokoro T; Katsuki S; Ito K; Onitsuka K; Nakashima A; Sasaguri T; Miyata K; Yamamoto H; Mohri M
Circ Heart Fail; 2017 Jan; 10(1):. PubMed ID: 28069686
[No Abstract] [Full Text] [Related]
43. Ten-year comparison of pericardial tissue valves versus mechanical prostheses for aortic valve replacement in patients younger than 60 years of age.
Weber A; Noureddine H; Englberger L; Dick F; Gahl B; Aymard T; Czerny M; Tevaearai H; Stalder M; Carrel TP
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1075-83. PubMed ID: 22341653
[TBL] [Abstract][Full Text] [Related]
44. Tricuspid valve replacement on a beating heart via a right minithoracotomy.
Salinas GE; Ramchandani M
Multimed Man Cardiothorac Surg; 2013; 2013():mmt006. PubMed ID: 24413005
[TBL] [Abstract][Full Text] [Related]
45. Outcome of cardiac surgery for carcinoid heart disease.
Connolly HM; Nishimura RA; Smith HC; Pellikka PA; Mullany CJ; Kvols LK
J Am Coll Cardiol; 1995 Feb; 25(2):410-6. PubMed ID: 7829795
[TBL] [Abstract][Full Text] [Related]
46. Image. Tricuspid and pulmonary valve involvement in carcinoid heart disease.
Ederhy S; Engel F; Cohen A
Arch Cardiovasc Dis; 2009; 102(6-7):591-2. PubMed ID: 19664582
[No Abstract] [Full Text] [Related]
47. Aortic valve replacement with the perceval S bioprosthesis: single-center experience in 143 patients.
Zannis K; Joffre J; Czitrom D; Folliguet T; Noghin M; Lansac MN; Mitchell-Heggs L; Debauchez M; Laborde F
J Heart Valve Dis; 2014 Nov; 23(6):795-802. PubMed ID: 25790630
[TBL] [Abstract][Full Text] [Related]
48. Tricuspid valve replacement: bioprostheses are preferable.
Dalrymple-Hay MJ; Leung Y; Ohri SK; Haw MP; Ross JK; Livesey SA; Monro JL
J Heart Valve Dis; 1999 Nov; 8(6):644-8. PubMed ID: 10616242
[TBL] [Abstract][Full Text] [Related]
49. A case of carcinoid heart disease with desaturation and no liver metastases.
Requilé A; Van De Bruaene A; Reenaers V; Dendale P
Echocardiography; 2014 Nov; 31(10):E307-9. PubMed ID: 25092066
[No Abstract] [Full Text] [Related]
50. Double porcine valve replacement in carcinoid heart disease.
Gutierrez FR; McKnight RC; Jaffe AS; Ludbrook PA; Biello D; Weldon CS
Chest; 1982 Jan; 81(1):101-3. PubMed ID: 7053927
[No Abstract] [Full Text] [Related]
51. Anesthetic considerations for valve replacement surgery in a patient with carcinoid syndrome.
Propst JW; Siegel LC; Stover EP
J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):209-12. PubMed ID: 7515709
[No Abstract] [Full Text] [Related]
52. Timing of peptide receptor radiotargeted therapy in relation to cardiac valve surgery for carcinoid heart disease in patients with neuroendocrine metastases and cardiac syndrome. A single-centre study from a centre of excellence.
Davis LM; Nicou N; Martin W; Corcoran B; Mulholland N; Srirajaskanthan R; Ramage J; Wendler O; Vivian G
Nucl Med Commun; 2020 Jun; 41(6):575-581. PubMed ID: 32371675
[TBL] [Abstract][Full Text] [Related]
53. Cardiac surgery for carcinoid heart disease in 12 cases.
Komoda S; Komoda T; Pavel ME; Morawietz L; Wiedenmann B; Hetzer R; Lehmkuhl HB
Gen Thorac Cardiovasc Surg; 2011 Dec; 59(12):780-5. PubMed ID: 22173674
[TBL] [Abstract][Full Text] [Related]
54. Late incidence and predictors of persistent or recurrent heart failure in patients with aortic prosthetic valves.
Ruel M; Rubens FD; Masters RG; Pipe AL; Bédard P; Hendry PJ; Lam BK; Burwash IG; Goldstein WG; Brais MP; Keon WJ; Mesana TG
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):149-59. PubMed ID: 14752425
[TBL] [Abstract][Full Text] [Related]
55. Carcinoid Heart Disease without Severe Tricuspid Valve Involvement.
Killu AM; Newman DB; Miranda WR; Maleszewski JJ; Pellikka P; Schaff HV; Connolly HM
Cardiology; 2016; 133(4):217-22. PubMed ID: 26666741
[TBL] [Abstract][Full Text] [Related]
56. Predictors of outcome of tricuspid valve replacement in carcinoid heart disease.
Robiolio PA; Rigolin VH; Harrison JK; Lowe JE; Moore JO; Bashore TM; Feldman JM
Am J Cardiol; 1995 Mar; 75(7):485-8. PubMed ID: 7863994
[TBL] [Abstract][Full Text] [Related]
57. Valvular Disorders in Carcinoid Heart Disease.
Yuan SM
Braz J Cardiovasc Surg; 2016; 31(5):400-405. PubMed ID: 27982350
[TBL] [Abstract][Full Text] [Related]
58. Early single-center experience in sutureless aortic valve implantation in 120 patients.
Eichstaedt HC; Easo J; Härle T; Dapunt OE
J Thorac Cardiovasc Surg; 2014 Jan; 147(1):370-5. PubMed ID: 23473011
[TBL] [Abstract][Full Text] [Related]
59. [Clinical outcome of totally thoracoscopic cardiac surgery for mitral valve replacement: a series of 634 cases].
Lan H; Cheng YG; Jia BC; Chai YL
Zhonghua Wai Ke Za Zhi; 2016 Aug; 54(8):609-12. PubMed ID: 27502136
[TBL] [Abstract][Full Text] [Related]
60. Quadruple valve replacement for valve destruction in carcinoid heart disease.
McAlindon E; Peterson M; Bryan A; Townsend M
Eur Heart J; 2011 Aug; 32(15):1946. PubMed ID: 21454342
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
